Table of Contents Table of Contents
Previous Page  564 / 1096 Next Page
Information
Show Menu
Previous Page 564 / 1096 Next Page
Page Background

S549

ESTRO 36

_______________________________________________________________________________________________

Results

While in 2D cultures of 518A2 melanoma cells, the

comparator substance cilengitide showed to be more

efficient than our novel compound NIA (IC50 value of

0,65µM), it had no inhibitory effect in 3D spheroid culture

up to 50µM. Comparatively NIA revealed to have similar

effectiveness in 2D as well as 3D cultures, both in the low

micromolar range. During monitoring of spheroid growth,

NIA treated spheroids initially depicted a growth

retardation, before cells started to disintegrate and die.

The radiosensitivity of 518A2 melanoma cells was found to

be similar in both culture conditions.

Conclusion

Similar differences in drug response and efficacy between

2D and 3D cell culture environments have been reported

for various anti-cancer substances as well as for some

radiation exposure endpoints. However, other endpoints

may - in a treatment-related manner - be depending on

the culture system used. We thus plan to perform further

comparative studies on survival-dependent aspects

(apoptosis, intracellular signaling, and others) with

integrin antagonists alone as well as in combination with

irradiation in 2D cell culture versus 3D spheroids.

PO-0995 Estimation of radiobiology parameters of

infiltrative low-grade gliomas WHO Grade II.

S. Milyukov

1

, Y. Lysak

2

, G. Panshin

2

, N. Kharchenko

1

, Z.

Tsallagova

2

, T. Izmailov

2

1

Peoples’ Friendship University of Russia, Department of

oncology and roentgenoradiology, Moscow, Russian

Federation

2

Russian Scientific Center of Roentgenoradiology of

Russia, Research department of innovative technologies

of radiotherapy and chemoradiation treatment of

malignant tumors, Moscow, Russian Federation

Purpose or Objective

Determine the value of radiobiological parameters of

infiltrative low-grade gliomas WHO Grade II

Material and Methods

In total (the data from) 5 clinical studies: EORTC 22844

(Karim AB et al., 1996.), EORTC 22845 (van den Bent MJ

et al., 2005), NCCTG 86-72-51 (Shaw E et al., 2002), the

RTOG 9802 (Shaw EG et. al., 2012), the study on the

hyperfractionated radiotherapy (Jeremic B et. al., 1998),

and selected data from our database were used for the

calculation radiobiological parameters of LGG. In total,

our study included 870 patients. All patients received

surgery (1-phase treatment) and radiotherapy (2-phase

treatment). Following radiobiological parameters of

radiotherapy were used for the calculation: dose per

fraction, total dose of radiotherapy, total number of

treatment days, 5-year progression-free survival.

Results

Following radiobiological parameters of infiltrative low-

grade gliomas WHO Grade II were calculated: α, β, α/β,

Td, D prolif, Tk, N clonogens. Following values were

calculated (95% Cl): α (Gr

– 1

) = 0,096 (0,08–0,11), β (Gr

–2

)

= 0,014 (0,012-0,018), α/β (Gr) = 6,8 (4,3-9,2), T

d

(days) =

21,3 (18,3-26,4), D

prolif

(Gr) = 0,27 (0,21-0,35), T

k

(days) =

44 (34-55), N

clonogens

= 2,18·10

3

(1,2-5,3) ·10

3

.

Conclusion

The calculated values of radiobiological parameters give a

better idea of the biological properties of the low-grade

gliomas and estimate as accurately as possible of the total

dose of radiotherapy using a linear-quadratic model.

Poster: RTT track: Patient preparation, positioning and

immobilisation

PO-0996 Accuracy of an optical surface monitoring

device to reduce daily imaging of breast cancer

patients

J. Sharpe

1

, A. Tini

1

, A. Moreira

1

, I. Pytko

1

, C. Winter

1

, M.

Guckenberger

1

, C. Linsenmeier

1

1

University Hospital of Zurich, Radiation Oncology Clinic,

Zurich, Switzerland

Purpose or Objective

To further test the positioning accuracy of an optical

surface monitoring device called Align RT for the

treatment of breast cancer patients. The data will then be

analyzed to determine if the daily positioning with Align

RT is accurate enough to allow for fewer weekly MV

imaging of breast radiotherapy patients.

Material and Methods

16 breast cancer patients were treated using 3D tangential

fields. Patients were positioned supine on the breast

board using an optical surface detector (Align RT). After

positioning, MV imaging and bone match on the chest wall

was done to verify the patients position, and corrected

accordingly. All shifted values were recorded. The Align

RT system consists of 6 cameras, which acquire the

patients’ position in 2D, and a computer vision algorithm,

which reconstructs the image into 3D. The patients’

reference surface was imported from the CT scan and the

region of interest of the treated area was selected. The

patient was positioned by using the Monitoring mode in

Align RT and driving couch values until pre-shift Align RT

deltas were as close to zero as possible. The Vertical

(VRT), Lateral (LAT), Longitudinal (LNG) shift values

generated from the MV images equal to or less than 5mm

were marked as falling within our accepted tolerance for

breast patients. This data was further analyzed to

conclude if it would be acceptably accurate enough to

reduce daily imaging.

Results

Out of the 16 patients involved in the study, a total of 213

fractions were treated using Align RT. Of these fractions,

201 (94.4%) had MV shift values, in all directions, within

our 5mm tolerance. 209 of 213 fractions (98%) were within

a 6mm tolerance or less. The largest shift observed was

9.5mm in the lateral direction, however the most frequent

axis that fell out of tolerance were VRT and LNG. The most

failed fractions (fractions with shift greater than 5mm)

observed from an individual patient was 3 out of her 25

recorded fractions. 9 of the 16 patients were treated with

all fractions within tolerance.

Conclusion

The data was found to be very consistent across all

patients, with 9 from 16 patients having all MV shifts equal

to or less than 5mm in all directions after using Align RT

for positioning and the remaining having minimal fractions

outside this tolerance. This data suggests a strong

argument for reducing daily imaging with breast patients

being positioned with Align RT. Reducing daily imaging to

2-3 times per week in combination with daily positioning

using Align RT would then be valuable in reduction of both

excess dose to the patient and treatment time on the

Linear accelerator.

PO-0997 Improving shoulder positioning in a 5-points

mask.

L. Mesch

1

, S. Hol

1

, G. D'Olieslager

2

, C. Buijs

1

, D.

Washington

1

1

Dr. Bernard Verbeeten Instituut, Department of

Radiation Oncology, Tilburg, The Netherlands

2

Dr. Bernard Verbeeten Instituut, Department of medical

Physics & Engineering, Tilburg, The Netherlands